New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...
Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...
9don MSN
“It’s like a personal sleep coach on your finger”: Oura Ring 4 vs Gen 3, tested for 6 months
Me 🤝 wearing my ring 24/7 ...
Abstract: This tutorial will present the technologies behind single-photon avalanche-diode (SPAD)-based solid-state CMOS LiDAR sensors that have emerged to realize level-5 automotive vehicles and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results